Device for the controlled delivery of a beneficial agent

• US 4,717,718 A
• Filed: 08/11/1986
• Issued: 01/05/1988
• Est. Priority Date: 08/09/1985
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Landrau, Felix A., Eckenhoff, James B., Cortese, Richard
• Primary Examiner(s): Griffin, Ronald W.
• Application Number:
  US06/895,612
• Time in Patent Office: 512 Days
• Field of Search: 514/30, 514/53, 536/7.1, 424/438
• US Class Current: 514/30
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50

Abstract

A device for the controlled delivery of a beneficial agent is disclosed. The device comprises (a) a formulation layer and (b) a layer comprising means for pushing the formualtion layer from said device. The formulation layer comprises the beneficial agent avermectin or ivermectin.

Claims

1. A device for the controlled delivery of a beneficial agent comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

, wherein the formulation layer comprises

the beneficial agent avermectin and a copolymer of 1,2-butylene oxide and ethylene oxide.

2. A device for the controlled delivery of a beneficial agent comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

, wherein the formulation layer comprises a beneficial agent selected from the group consisting of avermectin and ivermectin, and a member selected from the group consisting of a monoglyceride of a fatty acid, a diglyceride of a fatty acid, and a triglyceride of a fatty acid.

3. A delivery device for the controlled administration of a beneficial agent comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

, wherein the formulation layer comprises a beneficial agent selected from the group consisting of avermectin and ivermectin, and a member selected from the group consisting of partially hydrogenated plant, vegetable and animal fats, and completely hydrogenated plant, vegetable and animal fats.

4. A delivery device for the controlled administration of a beneficial agent comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

, wherein the formulation layer comprises a beneficial agent selected from the group consisting of avermectin and ivermectin and a member selected from the group consisting of an alkylene glycol fatty acid ester, and a polyalkylene glycol fatty acid ester.

5. A delivery device for the controlled administration of a beneficial agent comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

wherein the formulation layer comprises avermectin and a pharmaceutically acceptable wax.

6. The delivery device for the controlled administration of the beneficial agent according to claim 5, comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

, wherein the avermectin is ivermectin.

7. The delivery device for the controlled administration of a beneficial agent according to claim 5, comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device;

wherein the wax softens continuously at a temperature greater than 25°

C.

8. A delivery device for the controlled dispensing of a beneficial agent to an environment of use comprising:

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

, wherein the formulation layer comprises (c) an avermectin and (d) means for absorbing heat from the environment of use for dispensing the avermectin from the delivery device to the environment of use.

9. A delivery device for the controlled dispensing of a beneficial agent to an environment of use having a temperature greater than 25°

C. comprising;

(a) a formulation layer and (b) a layer comprising means for pushing the formulation layer from said device; and

wherein the formulation layer comprises means for absorbing thermal energy from the environment for forming a carrier for dispensing a beneficial agent to the environment, and a dosage unit amount of the beneficial agent ivermectin present in the means.